Uterine artery embolization for the treatment of uterine leiomyomata midterm results
Uterine artery embolization for the treatment of uterine leiomyomata midterm results
复制标题
DOI：
10.1016/s1051-0443(99)70213-7
复制
发表时间：
1999-10-01
影响因子：
2.9
通讯作者：
DeLeon, M
中科院分区：
文献类型：
--
作者：
Goodwin, SC;McLucas, B;DeLeon, M
简介：作者回顾了其子宫动脉栓塞治疗子宫肌瘤的中期经验，材料和方法：在18个月期间，60例患者接受永久性聚乙烯醇（PVA）泡沫颗粒子宫动脉栓塞。详细的临床随访和超声随访获得。结果：56例患者的主要症状是出血，47例患者的主要症状是疼痛。所有患者均接受了技术成功的栓塞，其中1例患者接受了单侧栓塞，59例患者接受了双侧栓塞，在所有接受双侧栓塞的患者中，末次随访（平均16.3个月）时，81%的患者具有子宫，症状有中度或更好的改善。这些患者中有92%的子宫和主要肌瘤体积也减少了。总体而言，平均子宫和显性肌瘤体积缩小分别为42.8%和48.8%（平均随访时间，10.2个月）。结论：子宫动脉栓塞术治疗子宫肌瘤是一种微创的治疗方法，并发症发生率低，临床疗效好。
INTRODUCTION: The authors review their midterm experience with uterine artery embolization for the treatment of uterine fibroids,MATERIALS AND METHODS: Sixty patients were referred for permanent polyvinyl alcohol (PVA) foam particle uterine artery embolization during an 18-month period. Detailed clinical follow-up and ultrasound follow-up were obtained.RESULTS: Bleeding was a presenting symptom in 56 patients and pain was a presenting symptom in 47 patients. All patients underwent a technically successful embolization, One of the patients underwent unilateral embolization, Fifty-nine patients underwent bilateral embolization, Of all patients undergoing bilateral embolization, at last follow-up (mean, 16.3 months), 81% had their uterus and had moderate or better improvement in their symptoms. Ninety-two percent of these patients also had reductions in uterine and dominant fibroid volumes. Overall, the mean uterine and dominant fibroid volume reduction were 42.8% and 48.8%, respectively (mean follow-up, 10.2 months). One infectious complication that necessitated hysterectomy occurred.CONCLUSION: Uterine artery embolization for the treatment of uterine fibroids is a minimally invasive technique with low complication rates and very good clinical efficacy.